MENU
NEUP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neuphoria Therapeutics (NEUP) Ownership - Who owns Neuphoria Therapeutics?

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.73M
P/E Ratio
0.78
Total Cash
19.44M
Projected Growth
N/A
Total Debt
34.23K
Revenue
-13.27K
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash/Share
3.60
Total Debt/Equity
N/A
Revenue/Share
-0.00 USD as % of share price
View a ticker or compare two or three
NEUP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details